Loading...

APC anti-mouse CD62L Antibody APC anti-mouse CD62L Antibody

Pricing & Availability
Clone
MEL-14 (See other available formats)
Regulatory Status
RUO
Other Names
L-selectin, LECAM-1, Ly-22, LAM-1, MEL-14
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
MEL-14_APC_090707
C57BL/6 mouse splenocytes were stained with CD62L (clone MEL-14) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
  • MEL-14_APC_090707
    C57BL/6 mouse splenocytes were stained with CD62L (clone MEL-14) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
104411 25 µg DKK393
Check Availability


Need larger quantities of this item?
Request Bulk Quote
104412 100 µg DKK1147
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD62L is a 74-95 kD glycoprotein also known as L-selectin, LECAM-1, Ly-22, LAM-1, and MEL-14. It is a member of the selectin family and is expressed on the majority of B and naïve T cells, a subset of memory T cells, monocytes, granulocytes, most thymocytes, and a subset of NK cells. CD62L is important in lymphocyte homing to high endothelial venules (HEV) in peripheral lymph nodes and leukocyte "rolling" on activated endothelium. CD62L also contributes to neutrophil emigration at inflammatory sites. CD62L is rapidly shed from lymphocytes and neutrophils upon cellular activation and the expression levels of CD62L (in conjunction with other markers) have been used to distinguish naïve, effector, and memory T cells. CD62L has been reported to interact with CD34, GlyCAM-1, and MAdCAM-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C3H/eb mouse B lymphoma 38C-13
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1-3, complement-dependent cytotoxicity4, in vivo and in vitro blocking of adhesion1-3,5, and immunohistochemical staining of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections6. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 104457-104462).

Application References
  1. Gallatin WM, et al. 1983. Nature 304:30. (IP, Block)
  2. Siegelman MH, et al. 1990. Cell 61:611. (IP, Block)
  3. Lewinsohn DM, et al. 1987. J. Immunol. 138:4313. (IP, Block)
  4. Iwabuchi K, et al. 1991. Immunobiology 182:161. (CMCD)
  5. Pizcueta P, et al. 1994. Am. J. Pathol. 145:461.
  6. Reichert RA, et al. 1986. J. Immunol. 136:3535. (IHC, FC)
  7. Olver S, et al. 2006. Cancer Res. 66:571.
  8. Fukushima A, et al. 2006. Invest. Ophthalmol. Vis. Sci. 47:657. PubMed
  9. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  10. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed
  11. Lee JW, et al. 2006. Nature Immunol. 8:181.
  12. Shigeta A, et al. 2008. Blood 112:4915 (FC) PubMed
  13. de Vries VC, et al. 2009. Am. J. Transplant. 9:2270 PubMed
Product Citations
  1. Jayachandran R, et al. 2019. Immunity. 50:152. PubMed
  2. Cowan J, et al. 2013. J Exp Med. 210:675. PubMed
  3. Ender F, et al. 2017. PLoS One. 12(2):e0172446. PubMed
  4. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  5. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  6. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  7. Ferrao Blanco MN, et al. 2022. Br J Pharmacol. 179:2771. PubMed
  8. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  9. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  10. Hu X, et al. 2022. EBioMedicine. 86:104333. PubMed
  11. Dölz M, et al. 2022. iScience. 25:105372. PubMed
  12. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  13. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  14. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  15. Battistello E, et al. 2023. Mol Cell. 83:1216. PubMed
  16. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  17. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  18. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  19. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  20. Scieszka DP, et al. 2023. Respir Res. 24:138. PubMed
  21. Milighetti M, et al. 2023. iScience. 26:106937. PubMed
  22. Martens R, et al. 2020. Nat Commun. 11:1114. PubMed
  23. Thi VAD, et al. 2019. Mol Cells. 42:869. PubMed
  24. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  25. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  26. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  27. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  28. Wang J, et al. 2012. Blood. 120:1489. PubMed
  29. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  30. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  31. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  32. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  33. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  34. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  35. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  36. Gilleron J et al. 2018. Cell reports. 25(12):3329-3341 . PubMed
  37. Shapiro MR, et al. 2020. Front Immunol. 1.972222222. PubMed
  38. Wei H, et al. 2021. Malar J. 20:89. PubMed
  39. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  40. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  41. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  42. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  43. Zhao Y, et al. 2021. J Biol Chem. 297:101166. PubMed
  44. Wiese A, et al. 2017. PLoS One. 10.1371/journal.pone.0184956. PubMed
  45. Roy S, et al. 2020. Sci Rep. 10:10992. PubMed
  46. Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed
  47. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  48. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  49. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  50. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  51. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  52. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  53. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  54. Li Y, et al. 2020. Nat Commun. 11:2781. PubMed
  55. Parriott G, et al. 2020. Immunology. 160:280. PubMed
  56. Ma X et al. 2019. Cell Metab. 30(1):143-156 . PubMed
  57. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  58. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  59. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  60. Deng B, et al. 2022. J Immunother Cancer. 10:. PubMed
  61. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  62. Sinclair LV et al. 2019. Elife. 8 pii: e44210. PubMed
  63. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  64. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  65. Ruer-Laventie J, et al. 2020. Bio Protoc. e3531:10. PubMed
  66. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  67. Kondratieva T, et al. 2020. PLoS One. 15:e0239668. PubMed
  68. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  69. Darragh LB, et al. 2022. Nat Commun. 13:7015. PubMed
  70. Glassman CR, et al. 2021. eLife. 10:00. PubMed
  71. Fu X, et al. 2020. Aging (Albany NY). 12:15656. PubMed
  72. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  73. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  74. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  75. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  76. Cowan J, et al. 2014. J Immunol. 193:1204. PubMed
  77. White C, et al. 2015. J Immunol. 194:697. PubMed
  78. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  79. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  80. Su X, et al. 2022. J Transl Med. 20:378. PubMed
  81. Morimoto Y, et al. 2018. Immunity. 49:134. PubMed
  82. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  83. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  84. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  85. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  86. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  87. Borges da Silva H, et al. 2020. Immunity. 53(1):158-171.e6. PubMed
  88. Ma K, et al. 2022. iScience. 25:104347. PubMed
  89. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  90. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  91. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  92. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  93. Jenkinson W, et al. 2012. PLoS One. 7:e53416. PubMed
  94. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  95. Roy S, et al. 2021. Nat Commun. 12:3182. PubMed
  96. Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
  97. Amezcua Vesely MC, et al. 2020. Cell. 178(5):1176-1188.e15.. PubMed
  98. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  99. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
  100. Shimba A et al. 2018. Immunity. 48(2):286-298 . PubMed
  101. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  102. Schaffert S, et al. 2015. J Immunol. 195: 1470-1479. PubMed
  103. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  104. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  105. Webb LM, et al. 2020. J Clin Invest. 130:1683. PubMed
  106. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  107. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  108. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  109. Lin JD, et al. 2020. Cell Host & Microbe. 27(5):830-840. PubMed
  110. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  111. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  112. Kooijman S, et al. 2015. Am J Physiol Heart Circ Physiol. 309: H646-H654. PubMed
  113. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  114. Rochford I, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 321:L686. PubMed
  115. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  116. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  117. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  118. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  119. Louise V Webb et al. 2019. Immunity. 50(2):348-361 . PubMed
  120. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  121. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  122. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  123. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  124. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  125. Yu Z, et al. 2021. Biomed Res Int. 2021:9958745. PubMed
  126. Jayachandran R, et al. 2019. Immunity. 50:152. PubMed
  127. Cowan J, et al. 2013. J Exp Med. 210:675. PubMed
  128. Ender F, et al. 2017. PLoS One. 12(2):e0172446. PubMed
  129. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  130. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  131. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  132. Ferrao Blanco MN, et al. 2022. Br J Pharmacol. 179:2771. PubMed
  133. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  134. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  135. Hu X, et al. 2022. EBioMedicine. 86:104333. PubMed
  136. Dölz M, et al. 2022. iScience. 25:105372. PubMed
  137. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  138. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  139. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  140. Battistello E, et al. 2023. Mol Cell. 83:1216. PubMed
  141. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  142. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  143. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  144. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  145. Scieszka DP, et al. 2023. Respir Res. 24:138. PubMed
  146. Milighetti M, et al. 2023. iScience. 26:106937. PubMed
  147. Martens R, et al. 2020. Nat Commun. 11:1114. PubMed
  148. Thi VAD, et al. 2019. Mol Cells. 42:869. PubMed
  149. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  150. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  151. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  152. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  153. Wang J, et al. 2012. Blood. 120:1489. PubMed
  154. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  155. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  156. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  157. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  158. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  159. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  160. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  161. Gilleron J et al. 2018. Cell reports. 25(12):3329-3341 . PubMed
  162. Shapiro MR, et al. 2020. Front Immunol. 1.972222222. PubMed
  163. Wei H, et al. 2021. Malar J. 20:89. PubMed
  164. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  165. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  166. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  167. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  168. Zhao Y, et al. 2021. J Biol Chem. 297:101166. PubMed
  169. Wiese A, et al. 2017. PLoS One. 10.1371/journal.pone.0184956. PubMed
  170. Roy S, et al. 2020. Sci Rep. 10:10992. PubMed
  171. Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed
  172. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  173. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  174. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  175. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  176. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  177. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  178. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  179. Li Y, et al. 2020. Nat Commun. 11:2781. PubMed
  180. Parriott G, et al. 2020. Immunology. 160:280. PubMed
  181. Ma X et al. 2019. Cell Metab. 30(1):143-156 . PubMed
  182. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  183. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  184. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  185. Deng B, et al. 2022. J Immunother Cancer. 10:. PubMed
  186. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  187. Sinclair LV et al. 2019. Elife. 8 pii: e44210. PubMed
  188. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  189. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  190. Ruer-Laventie J, et al. 2020. Bio Protoc. e3531:10. PubMed
  191. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  192. Kondratieva T, et al. 2020. PLoS One. 15:e0239668. PubMed
  193. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  194. Darragh LB, et al. 2022. Nat Commun. 13:7015. PubMed
  195. Glassman CR, et al. 2021. eLife. 10:00. PubMed
  196. Fu X, et al. 2020. Aging (Albany NY). 12:15656. PubMed
  197. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  198. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  199. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  200. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  201. Cowan J, et al. 2014. J Immunol. 193:1204. PubMed
  202. White C, et al. 2015. J Immunol. 194:697. PubMed
  203. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  204. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  205. Su X, et al. 2022. J Transl Med. 20:378. PubMed
  206. Morimoto Y, et al. 2018. Immunity. 49:134. PubMed
  207. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  208. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  209. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  210. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  211. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  212. Borges da Silva H, et al. 2020. Immunity. 53(1):158-171.e6. PubMed
  213. Ma K, et al. 2022. iScience. 25:104347. PubMed
  214. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  215. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  216. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  217. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  218. Jenkinson W, et al. 2012. PLoS One. 7:e53416. PubMed
  219. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  220. Roy S, et al. 2021. Nat Commun. 12:3182. PubMed
  221. Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
  222. Amezcua Vesely MC, et al. 2020. Cell. 178(5):1176-1188.e15.. PubMed
  223. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  224. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
  225. Shimba A et al. 2018. Immunity. 48(2):286-298 . PubMed
  226. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  227. Schaffert S, et al. 2015. J Immunol. 195: 1470-1479. PubMed
  228. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  229. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  230. Webb LM, et al. 2020. J Clin Invest. 130:1683. PubMed
  231. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  232. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  233. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  234. Lin JD, et al. 2020. Cell Host & Microbe. 27(5):830-840. PubMed
  235. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  236. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  237. Kooijman S, et al. 2015. Am J Physiol Heart Circ Physiol. 309: H646-H654. PubMed
  238. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  239. Rochford I, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 321:L686. PubMed
  240. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  241. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  242. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  243. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  244. Louise V Webb et al. 2019. Immunity. 50(2):348-361 . PubMed
  245. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  246. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  247. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  248. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  249. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  250. Yu Z, et al. 2021. Biomed Res Int. 2021:9958745. PubMed
RRID
AB_313098 (BioLegend Cat. No. 104411)
AB_313099 (BioLegend Cat. No. 104412)

Antigen Details

Structure
Selectin, 95 kD (neutrophils) or 74 kD (lymphocytes)
Distribution

Subsets of B and T cells, monocytes, granulocytes, subset of NK cells

Function
Lymphocyte homing to HEV, rolling on activated endothelium
Ligand/Receptor
CD34, GlyCAM-1, MAdCAM-1
Cell Type
B cells, Granulocytes, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Kishimoto TK, et al. 1990. P. Natl. Acad. Sci. USA 87:2244.
3. Tedder TF, et al. 1995. J. Exp. Med. 181:2259.

Gene ID
20343 View all products for this Gene ID
UniProt
View information about CD62L on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD62L Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse CD62L MEL-14 FC
Brilliant Violet 711™ anti-mouse CD62L MEL-14 FC
Brilliant Violet 785™ anti-mouse CD62L MEL-14 FC
PE/Dazzle™ 594 anti-mouse CD62L MEL-14 FC
APC/Fire™ 750 anti-mouse CD62L MEL-14 FC
TotalSeq™-A0112 anti-mouse CD62L MEL-14 PG
Brilliant Violet 650™ anti-mouse CD62L MEL-14 FC
TotalSeq™-C0112 anti-mouse CD62L MEL-14 PG
KIRAVIA Blue 520™ anti-mouse CD62L MEL-14 FC
Ultra-LEAF™ Purified anti-mouse CD62L MEL-14 FC,CyTOF®,IHC-F,IP,CMCD,Block
TotalSeq™-B0112 anti-mouse CD62L MEL-14 PG
APC anti-mouse CD62L MEL-14 FC
Biotin anti-mouse CD62L MEL-14 FC
FITC anti-mouse CD62L MEL-14 FC
PE anti-mouse CD62L MEL-14 FC
PE/Cyanine5 anti-mouse CD62L MEL-14 FC
Purified anti-mouse CD62L MEL-14 FC,CyTOF®,IHC-F,IP
Alexa Fluor® 488 anti-mouse CD62L MEL-14 FC
Alexa Fluor® 647 anti-mouse CD62L MEL-14 FC
Pacific Blue™ anti-mouse CD62L MEL-14 FC
Alexa Fluor® 700 anti-mouse CD62L MEL-14 FC
APC/Cyanine7 anti-mouse CD62L MEL-14 FC
PerCP/Cyanine5.5 anti-mouse CD62L MEL-14 FC
PerCP anti-mouse CD62L MEL-14 FC
Brilliant Violet 421™ anti-mouse CD62L MEL-14 FC
Brilliant Violet 570™ anti-mouse CD62L MEL-14 FC
Brilliant Violet 605™ anti-mouse CD62L MEL-14 FC
Brilliant Violet 510™ anti-mouse CD62L MEL-14 FC
Purified anti-mouse CD62L (Maxpar® Ready) MEL-14 FC,CyTOF®
Spark Red™ 718 anti-mouse CD62L (Flexi-Fluor™) MEL-14 FC
Spark PLUS B550™ anti-mouse CD62L MEL-14 FC
Spark YG™ 581 anti-mouse CD62L (Flexi-Fluor™) MEL-14 FC
Spark YG™ 593 anti-mouse CD62L (Flexi-Fluor™) Antibody MEL-14 FC
Spark NIR™ 685 anti-mouse CD62L (Flexi-Fluor™) Antibody MEL-14 FC
Spark UV™ 387 anti-mouse CD62L (Flexi-Fluor™) MEL-14 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
MEL-14 (See other available formats)
Regulatory Status
RUO
Other Names
L-selectin, LECAM-1, Ly-22, LAM-1, MEL-14
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
MEL-14_APC_090707
C57BL/6 mouse splenocytes were stained with CD62L (clone MEL-14) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
  • MEL-14_APC_090707
    C57BL/6 mouse splenocytes were stained with CD62L (clone MEL-14) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
104411 25 µg DKK393
Check Availability


Need larger quantities of this item?
Request Bulk Quote
104412 100 µg DKK1147
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD62L is a 74-95 kD glycoprotein also known as L-selectin, LECAM-1, Ly-22, LAM-1, and MEL-14. It is a member of the selectin family and is expressed on the majority of B and naïve T cells, a subset of memory T cells, monocytes, granulocytes, most thymocytes, and a subset of NK cells. CD62L is important in lymphocyte homing to high endothelial venules (HEV) in peripheral lymph nodes and leukocyte "rolling" on activated endothelium. CD62L also contributes to neutrophil emigration at inflammatory sites. CD62L is rapidly shed from lymphocytes and neutrophils upon cellular activation and the expression levels of CD62L (in conjunction with other markers) have been used to distinguish naïve, effector, and memory T cells. CD62L has been reported to interact with CD34, GlyCAM-1, and MAdCAM-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C3H/eb mouse B lymphoma 38C-13
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1-3, complement-dependent cytotoxicity4, in vivo and in vitro blocking of adhesion1-3,5, and immunohistochemical staining of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections6. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 104457-104462).

Application References
  1. Gallatin WM, et al. 1983. Nature 304:30. (IP, Block)
  2. Siegelman MH, et al. 1990. Cell 61:611. (IP, Block)
  3. Lewinsohn DM, et al. 1987. J. Immunol. 138:4313. (IP, Block)
  4. Iwabuchi K, et al. 1991. Immunobiology 182:161. (CMCD)
  5. Pizcueta P, et al. 1994. Am. J. Pathol. 145:461.
  6. Reichert RA, et al. 1986. J. Immunol. 136:3535. (IHC, FC)
  7. Olver S, et al. 2006. Cancer Res. 66:571.
  8. Fukushima A, et al. 2006. Invest. Ophthalmol. Vis. Sci. 47:657. PubMed
  9. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  10. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed
  11. Lee JW, et al. 2006. Nature Immunol. 8:181.
  12. Shigeta A, et al. 2008. Blood 112:4915 (FC) PubMed
  13. de Vries VC, et al. 2009. Am. J. Transplant. 9:2270 PubMed
Product Citations
  1. Jayachandran R, et al. 2019. Immunity. 50:152. PubMed
  2. Cowan J, et al. 2013. J Exp Med. 210:675. PubMed
  3. Ender F, et al. 2017. PLoS One. 12(2):e0172446. PubMed
  4. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  5. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  6. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  7. Ferrao Blanco MN, et al. 2022. Br J Pharmacol. 179:2771. PubMed
  8. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  9. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  10. Hu X, et al. 2022. EBioMedicine. 86:104333. PubMed
  11. Dölz M, et al. 2022. iScience. 25:105372. PubMed
  12. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  13. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  14. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  15. Battistello E, et al. 2023. Mol Cell. 83:1216. PubMed
  16. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  17. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  18. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  19. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  20. Scieszka DP, et al. 2023. Respir Res. 24:138. PubMed
  21. Milighetti M, et al. 2023. iScience. 26:106937. PubMed
  22. Martens R, et al. 2020. Nat Commun. 11:1114. PubMed
  23. Thi VAD, et al. 2019. Mol Cells. 42:869. PubMed
  24. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  25. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  26. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  27. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  28. Wang J, et al. 2012. Blood. 120:1489. PubMed
  29. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  30. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  31. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  32. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  33. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  34. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  35. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  36. Gilleron J et al. 2018. Cell reports. 25(12):3329-3341 . PubMed
  37. Shapiro MR, et al. 2020. Front Immunol. 1.972222222. PubMed
  38. Wei H, et al. 2021. Malar J. 20:89. PubMed
  39. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  40. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  41. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  42. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  43. Zhao Y, et al. 2021. J Biol Chem. 297:101166. PubMed
  44. Wiese A, et al. 2017. PLoS One. 10.1371/journal.pone.0184956. PubMed
  45. Roy S, et al. 2020. Sci Rep. 10:10992. PubMed
  46. Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed
  47. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  48. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  49. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  50. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  51. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  52. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  53. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  54. Li Y, et al. 2020. Nat Commun. 11:2781. PubMed
  55. Parriott G, et al. 2020. Immunology. 160:280. PubMed
  56. Ma X et al. 2019. Cell Metab. 30(1):143-156 . PubMed
  57. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  58. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  59. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  60. Deng B, et al. 2022. J Immunother Cancer. 10:. PubMed
  61. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  62. Sinclair LV et al. 2019. Elife. 8 pii: e44210. PubMed
  63. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  64. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  65. Ruer-Laventie J, et al. 2020. Bio Protoc. e3531:10. PubMed
  66. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  67. Kondratieva T, et al. 2020. PLoS One. 15:e0239668. PubMed
  68. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  69. Darragh LB, et al. 2022. Nat Commun. 13:7015. PubMed
  70. Glassman CR, et al. 2021. eLife. 10:00. PubMed
  71. Fu X, et al. 2020. Aging (Albany NY). 12:15656. PubMed
  72. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  73. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  74. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  75. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  76. Cowan J, et al. 2014. J Immunol. 193:1204. PubMed
  77. White C, et al. 2015. J Immunol. 194:697. PubMed
  78. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  79. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  80. Su X, et al. 2022. J Transl Med. 20:378. PubMed
  81. Morimoto Y, et al. 2018. Immunity. 49:134. PubMed
  82. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  83. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  84. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  85. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  86. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  87. Borges da Silva H, et al. 2020. Immunity. 53(1):158-171.e6. PubMed
  88. Ma K, et al. 2022. iScience. 25:104347. PubMed
  89. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  90. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  91. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  92. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  93. Jenkinson W, et al. 2012. PLoS One. 7:e53416. PubMed
  94. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  95. Roy S, et al. 2021. Nat Commun. 12:3182. PubMed
  96. Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
  97. Amezcua Vesely MC, et al. 2020. Cell. 178(5):1176-1188.e15.. PubMed
  98. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  99. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
  100. Shimba A et al. 2018. Immunity. 48(2):286-298 . PubMed
  101. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  102. Schaffert S, et al. 2015. J Immunol. 195: 1470-1479. PubMed
  103. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  104. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  105. Webb LM, et al. 2020. J Clin Invest. 130:1683. PubMed
  106. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  107. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  108. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  109. Lin JD, et al. 2020. Cell Host & Microbe. 27(5):830-840. PubMed
  110. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  111. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  112. Kooijman S, et al. 2015. Am J Physiol Heart Circ Physiol. 309: H646-H654. PubMed
  113. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  114. Rochford I, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 321:L686. PubMed
  115. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  116. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  117. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  118. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  119. Louise V Webb et al. 2019. Immunity. 50(2):348-361 . PubMed
  120. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  121. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  122. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  123. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  124. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  125. Yu Z, et al. 2021. Biomed Res Int. 2021:9958745. PubMed
  126. Jayachandran R, et al. 2019. Immunity. 50:152. PubMed
  127. Cowan J, et al. 2013. J Exp Med. 210:675. PubMed
  128. Ender F, et al. 2017. PLoS One. 12(2):e0172446. PubMed
  129. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  130. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  131. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  132. Ferrao Blanco MN, et al. 2022. Br J Pharmacol. 179:2771. PubMed
  133. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  134. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  135. Hu X, et al. 2022. EBioMedicine. 86:104333. PubMed
  136. Dölz M, et al. 2022. iScience. 25:105372. PubMed
  137. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  138. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  139. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  140. Battistello E, et al. 2023. Mol Cell. 83:1216. PubMed
  141. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  142. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  143. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  144. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  145. Scieszka DP, et al. 2023. Respir Res. 24:138. PubMed
  146. Milighetti M, et al. 2023. iScience. 26:106937. PubMed
  147. Martens R, et al. 2020. Nat Commun. 11:1114. PubMed
  148. Thi VAD, et al. 2019. Mol Cells. 42:869. PubMed
  149. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  150. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  151. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  152. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  153. Wang J, et al. 2012. Blood. 120:1489. PubMed
  154. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  155. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  156. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  157. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  158. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  159. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  160. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  161. Gilleron J et al. 2018. Cell reports. 25(12):3329-3341 . PubMed
  162. Shapiro MR, et al. 2020. Front Immunol. 1.972222222. PubMed
  163. Wei H, et al. 2021. Malar J. 20:89. PubMed
  164. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  165. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  166. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  167. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  168. Zhao Y, et al. 2021. J Biol Chem. 297:101166. PubMed
  169. Wiese A, et al. 2017. PLoS One. 10.1371/journal.pone.0184956. PubMed
  170. Roy S, et al. 2020. Sci Rep. 10:10992. PubMed
  171. Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed
  172. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  173. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  174. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  175. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  176. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  177. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  178. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  179. Li Y, et al. 2020. Nat Commun. 11:2781. PubMed
  180. Parriott G, et al. 2020. Immunology. 160:280. PubMed
  181. Ma X et al. 2019. Cell Metab. 30(1):143-156 . PubMed
  182. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  183. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  184. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  185. Deng B, et al. 2022. J Immunother Cancer. 10:. PubMed
  186. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  187. Sinclair LV et al. 2019. Elife. 8 pii: e44210. PubMed
  188. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  189. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  190. Ruer-Laventie J, et al. 2020. Bio Protoc. e3531:10. PubMed
  191. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  192. Kondratieva T, et al. 2020. PLoS One. 15:e0239668. PubMed
  193. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  194. Darragh LB, et al. 2022. Nat Commun. 13:7015. PubMed
  195. Glassman CR, et al. 2021. eLife. 10:00. PubMed
  196. Fu X, et al. 2020. Aging (Albany NY). 12:15656. PubMed
  197. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  198. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  199. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  200. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  201. Cowan J, et al. 2014. J Immunol. 193:1204. PubMed
  202. White C, et al. 2015. J Immunol. 194:697. PubMed
  203. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  204. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  205. Su X, et al. 2022. J Transl Med. 20:378. PubMed
  206. Morimoto Y, et al. 2018. Immunity. 49:134. PubMed
  207. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  208. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  209. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  210. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  211. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  212. Borges da Silva H, et al. 2020. Immunity. 53(1):158-171.e6. PubMed
  213. Ma K, et al. 2022. iScience. 25:104347. PubMed
  214. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  215. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  216. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  217. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  218. Jenkinson W, et al. 2012. PLoS One. 7:e53416. PubMed
  219. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  220. Roy S, et al. 2021. Nat Commun. 12:3182. PubMed
  221. Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
  222. Amezcua Vesely MC, et al. 2020. Cell. 178(5):1176-1188.e15.. PubMed
  223. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  224. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
  225. Shimba A et al. 2018. Immunity. 48(2):286-298 . PubMed
  226. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  227. Schaffert S, et al. 2015. J Immunol. 195: 1470-1479. PubMed
  228. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  229. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  230. Webb LM, et al. 2020. J Clin Invest. 130:1683. PubMed
  231. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  232. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  233. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  234. Lin JD, et al. 2020. Cell Host & Microbe. 27(5):830-840. PubMed
  235. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  236. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  237. Kooijman S, et al. 2015. Am J Physiol Heart Circ Physiol. 309: H646-H654. PubMed
  238. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  239. Rochford I, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 321:L686. PubMed
  240. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  241. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  242. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  243. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  244. Louise V Webb et al. 2019. Immunity. 50(2):348-361 . PubMed
  245. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  246. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  247. Hodgson R, et al. 2022. Commun Biol. 5:1216. PubMed
  248. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  249. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  250. Yu Z, et al. 2021. Biomed Res Int. 2021:9958745. PubMed
RRID
AB_313098 (BioLegend Cat. No. 104411)
AB_313099 (BioLegend Cat. No. 104412)

Antigen Details

Structure
Selectin, 95 kD (neutrophils) or 74 kD (lymphocytes)
Distribution

Subsets of B and T cells, monocytes, granulocytes, subset of NK cells

Function
Lymphocyte homing to HEV, rolling on activated endothelium
Ligand/Receptor
CD34, GlyCAM-1, MAdCAM-1
Cell Type
B cells, Granulocytes, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Kishimoto TK, et al. 1990. P. Natl. Acad. Sci. USA 87:2244.
3. Tedder TF, et al. 1995. J. Exp. Med. 181:2259.

Gene ID
20343 View all products for this Gene ID
UniProt
View information about CD62L on UniProt.org

Other Formats

View All CD62L Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse CD62L MEL-14 FC
Brilliant Violet 711™ anti-mouse CD62L MEL-14 FC
Brilliant Violet 785™ anti-mouse CD62L MEL-14 FC
PE/Dazzle™ 594 anti-mouse CD62L MEL-14 FC
APC/Fire™ 750 anti-mouse CD62L MEL-14 FC
TotalSeq™-A0112 anti-mouse CD62L MEL-14 PG
Brilliant Violet 650™ anti-mouse CD62L MEL-14 FC
TotalSeq™-C0112 anti-mouse CD62L MEL-14 PG
KIRAVIA Blue 520™ anti-mouse CD62L MEL-14 FC
Ultra-LEAF™ Purified anti-mouse CD62L MEL-14 FC,CyTOF®,IHC-F,IP,CMCD,Block
TotalSeq™-B0112 anti-mouse CD62L MEL-14 PG
APC anti-mouse CD62L MEL-14 FC
Biotin anti-mouse CD62L MEL-14 FC
FITC anti-mouse CD62L MEL-14 FC
PE anti-mouse CD62L MEL-14 FC
PE/Cyanine5 anti-mouse CD62L MEL-14 FC
Purified anti-mouse CD62L MEL-14 FC,CyTOF®,IHC-F,IP
Alexa Fluor® 488 anti-mouse CD62L MEL-14 FC
Alexa Fluor® 647 anti-mouse CD62L MEL-14 FC
Pacific Blue™ anti-mouse CD62L MEL-14 FC
Alexa Fluor® 700 anti-mouse CD62L MEL-14 FC
APC/Cyanine7 anti-mouse CD62L MEL-14 FC
PerCP/Cyanine5.5 anti-mouse CD62L MEL-14 FC
PerCP anti-mouse CD62L MEL-14 FC
Brilliant Violet 421™ anti-mouse CD62L MEL-14 FC
Brilliant Violet 570™ anti-mouse CD62L MEL-14 FC
Brilliant Violet 605™ anti-mouse CD62L MEL-14 FC
Brilliant Violet 510™ anti-mouse CD62L MEL-14 FC
Purified anti-mouse CD62L (Maxpar® Ready) MEL-14 FC,CyTOF®
Spark Red™ 718 anti-mouse CD62L (Flexi-Fluor™) MEL-14 FC
Spark PLUS B550™ anti-mouse CD62L MEL-14 FC
Spark YG™ 581 anti-mouse CD62L (Flexi-Fluor™) MEL-14 FC
Spark YG™ 593 anti-mouse CD62L (Flexi-Fluor™) Antibody MEL-14 FC
Spark NIR™ 685 anti-mouse CD62L (Flexi-Fluor™) Antibody MEL-14 FC
Spark UV™ 387 anti-mouse CD62L (Flexi-Fluor™) MEL-14 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account